BioArctic AB (LTS:0RV2) Cyclically Adjusted Book per Share: kr12.16 (As of Mar. 2026)


LTS:0RV2 BioArctic AB LTS:0RV2
76 GF Score
Price kr319.50
GF Value kr482.70
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is BioArctic AB Cyclically Adjusted Book per Share?

BioArctic AB LTS:0RV2 -1.57% 76 Cyclically Adjusted Book per Share is kr12.16 as of Mar. 2026. GuruFocus rates LTS:0RV2 with a GF Score™ of 76/100 and a GF Value™ of kr482.70 (Significantly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

BioArctic AB's adjusted book value per share for the three months ended in Mar. 2026 was kr24.775. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr12.16 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-08), BioArctic AB's current stock price is kr319.50. BioArctic AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was kr12.16. BioArctic AB's Cyclically Adjusted PB Ratio of today is 26.27.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of BioArctic AB was 29.29. The lowest was 24.89. And the median was 26.82.


BioArctic AB  (LTS:0RV2) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

BioArctic AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=319.50/12.16
=26.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of BioArctic AB was 29.29. The lowest was 24.89. And the median was 26.82.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


BioArctic AB Cyclically Adjusted Book per Share Related Terms


BioArctic AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for BioArctic AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioArctic AB Cyclically Adjusted Book per Share Chart

BioArctic AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BioArctic AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 12.16

LTS:0RV2 vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, BioArctic AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioArctic AB Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioArctic AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BioArctic AB's Cyclically Adjusted PB Ratio falls into.


LTS:0RV2
76GF Score
BioArctic AB LTS:0RV2
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioArctic AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioArctic AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=24.775/133.5600*133.5600
=24.775

Current CPI (Mar. 2026) = 133.5600.

BioArctic AB Quarterly Data

Book Value per Share CPI Adj_Book
201512 1.230 100.276 1.638
201609 0.000 101.138 0.000
201612 0.690 102.022 0.903
201703 0.000 102.022 0.000
201706 0.729 102.752 0.948
201709 0.728 103.279 0.941
201712 7.224 103.793 9.296
201803 7.399 103.962 9.506
201806 7.457 104.875 9.497
201809 7.751 105.679 9.796
201812 11.557 105.912 14.574
201903 11.712 105.886 14.773
201906 11.351 106.742 14.203
201909 11.257 107.214 14.023
201912 11.066 107.766 13.715
202003 11.110 106.563 13.925
202006 10.680 107.498 13.269
202009 10.449 107.635 12.966
202012 10.303 108.296 12.707
202103 9.977 108.360 12.297
202106 9.588 108.928 11.756
202109 9.166 110.338 11.095
202112 8.956 112.486 10.634
202203 8.462 114.825 9.843
202206 7.949 118.384 8.968
202209 9.509 122.296 10.385
202212 8.921 126.365 9.429
202303 12.308 127.042 12.940
202306 11.267 129.407 11.629
202309 12.783 130.224 13.111
202312 11.850 131.912 11.998
202403 11.240 132.205 11.355
202406 10.521 132.716 10.588
202409 10.395 132.304 10.494
202412 10.125 132.987 10.169
202503 21.846 132.825 21.967
202506 22.999 133.699 22.975
202509 22.217 133.480 22.230
202512 22.192 133.390 22.220
202603 24.775 133.560 24.775

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr12.16 mean?
BioArctic AB (LTS:0RV2) has a Cyclically Adjusted Book per Share of kr12.16 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on BioArctic AB and its competitors.
Is BioArctic AB's Cyclically Adjusted Book per Share too high?
BioArctic AB's current Cyclically Adjusted Book per Share is kr12.16. Overall, BioArctic AB has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BioArctic AB's Cyclically Adjusted Book per Share compare to VRTX and REGN?
BioArctic AB's Cyclically Adjusted Book per Share of kr12.16 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on BioArctic AB and its competitors. BioArctic AB's current Cyclically Adjusted Book per Share is kr12.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioArctic AB stock overvalued right now?
Based on GuruFocus' analysis, BioArctic AB (LTS:0RV2) is currently considered Significantly Undervalued. The stock's GF Value™ is kr482.70, compared to a current price of kr319.50 — trading 33.8% below its estimated fair value. The current Cyclically Adjusted Book per Share is kr12.16. BioArctic AB's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For BioArctic AB (LTS:0RV2), the current Cyclically Adjusted Book per Share is kr12.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioArctic AB (LTS:0RV2) Overvalued in 2026?

Based on GuruFocus' analysis, BioArctic AB stock appears to be undervalued. The current stock price of kr319.50 is trading 33.8% below its estimated GF Value™ of kr482.70. GuruFocus considers BioArctic AB to be Significantly Undervalued.

Key valuation signals for LTS:0RV2:

  • Cyclically Adjusted Book per Share: kr12.16
  • GF Value™: kr482.70 vs. price of kr319.50 (33.8% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the LTS:0RV2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioArctic AB Business Description

Address Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
76GF Score

Get the complete analysis for LTS:0RV2

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr319.50
Price
kr482.70
GF Value